Abstract
A mesoporous silica-based drug delivery system (MS@PNIPAm-PAAm NPs) was synthesized by conjugating the PNIPAm-PAAm copolymer onto the mesoporous silica (MS) surface as a gatekeeper that responds to temperature and pH changes. The drug delivery studies are carried out in vitro at different pH (7.4, 6.5, and 5.0) and temperatures (such as 25 °C and 42 °C, respectively). The surface conjugated copolymer (PNIPAm-PAAm) acts as a gatekeeper below the lower critical solution temperature (LCST) (<32 °C) and as a collapsed globule structure above LCST (>32 °C), resulting in controlled drug delivery from the MS@PNIPAm-PAAm system. Furthermore, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and cellular internalization results support the prepared MS@PNIPAm-PAAm NPs being biocompatible and readily taken up by MDA-MB-231 cells. The prepared MS@PNIPAm-PAAm NPs, with their pH-responsive drug release behavior and good biocompatibility, could be used as a drug delivery vehicle where sustained drug release at higher temperatures is required.
Author supplied keywords
Cite
CITATION STYLE
Thirupathi, K., Santhamoorthy, M., Radhakrishnan, S., Ulagesan, S., Nam, T. J., Phan, T. T. V., & Kim, S. C. (2023). Thermosensitive Polymer-Modified Mesoporous Silica for pH and Temperature-Responsive Drug Delivery. Pharmaceutics, 15(3). https://doi.org/10.3390/pharmaceutics15030795
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.